AEGiS-UPI: HIV in elderly presents unique challenges United Press InternationalImportant note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article

HIV in elderly presents unique challenges

United Press International - March 19, 2002
Koren Capozza, UPI Science News


SAN FRANCISCO -- The elderly living with HIV often face a double stigma -- the fact the disease is associated with sexual activity and drug abuse and simply that they are old, experts said Tuesday at an AIDS research meeting.

Presentations at the American Foundation for AIDS Research meeting shed new light on the unique issues facing HIV patients over age 50.

"When I was speaking to a high school class, a teenage girl said: 'Look, we all know we're going to die someday and you're already old so what's the big deal?'" said Jane Fowler, 66, who is HIV-positive and the national coordinator of the National Association on HIV Over Fifty. "We face a double stigma."

Today between 11 percent and 15 percent of Americans infected with the human immunodeficiency virus are over age 50.

One of the biggest challenges for care providers working with elderly patients who may be at risk for HIV infection is distinguishing between symptoms which are hallmarks of aging -- like fatigue, memory loss and digestive problems -- and those which are indicative of HIV.

Moreover, many care providers do not even look for sexually transmitted diseases in older patients because of the prevailing myth they are no longer sexually active.

In fact, increasing evidence indicates older women are particularly susceptible to HIV-infection because the vaginal wall thins with age, increasing the risk of transmission through sexual intercourse. And post-menopausal women may not see the need for condom use when they are no longer at risk for pregnancy.

Once older patients have been diagnosed, they face new challenges with the drug treatment, called anti-retroviral therapy, prescribed to keep HIV levels at very low -- sometimes undetectable -- levels.

"A lot of the anti-retroviral drugs have side effects that are similar to the kind of conditions you see in an aging population anyway: Type 2 diabetes, osteoporosis and high cholesterol," said Donna Gallagher, director of the New England AIDS Education and Training Center in Boston. "But they're getting these things 20 years before they're supposed to."

Few studies have compared survival rates between younger and older HIV-infected patients but preliminary research suggests the elderly may die sooner.

"Studies have shown that olders (patients)were more likely to have decreased survival after diagnosis of HIV but those studies were confounded by a bias against making a diagnosis in olders. They were only diagnosed after an AIDS-defining illness," said Dr. Karl Goodkin, a psychiatrist at the University of Miami who studies survival rates in younger and older HIV-infected patients.

He said he hopes to determine if late diagnoses are driving lower survival in elderly patients or if HIV affects older people differently.

"People over 50, have an immune system that's on the down-swing," Gallagher said. The side effects of the anti-retroviral drugs tend to compound conditions associated with aging, causing HIV-positive people over 50 to die of complications linked to conditions like high cholesterol.

"If you already had a little bit of high cholesterol and then the medication tripled it, that may be what pushes people over the edge," she said.

Health providers face a another challenge in treating elderly HIV-positive patients. Very little research has been done on how drugs for common conditions like high blood pressure and hormone replacement therapy interact with anti-retroviral drugs.

"As people that are HIV-positive and young today continue to live, we'll learn more and more about these problems," Fowler said.
020319
UP020305


Copyright © 2002 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .